---
granola_id: 3368f2dc-d88e-4ba0-9f86-b208df4f5a4c
title: "Virtue / Autonomy"
type: note
created: 2026-01-20T17:33:23.487Z
updated: 2026-01-20T18:21:26.471Z
attendees: 
  - natalie@autonomyhealth.io
  - rooshil@autonomyhealth.io
  - ek@virtuevc.com
---
### JP Morgan Healthcare Conference Takeaways

- Strong activity on bio side, especially AI-powered drug discovery
- Licensing models gaining traction, though execution remains uncertain
- Continuing investor uncertainty about defensibility in pure software realm
	- Lack of confidence on 2-year vs 5-10 year prospects
	- Rev cycle/prior auth AI still seeking durable competitive moats

### Series A Market Dynamics

- Difficult funding environment with wide spectrum of outcomes
- Two successful company profiles emerging:
- Key success factors for Series A:
	- Concentrated talent at seed stage
	- Fast deal closure times (weeks not months)
	- Strong pipeline momentum with quantified projections
	- High-caliber team additions signaling real innovation

### Autonomy Product & Strategy Update

- Core MSO focus unchanged: automate neurology practice management starting with infusions
- Pharmacy strategy development due to ASP pressure under Trump administration
	- Exploring 340B partnerships for better drug margins
	- Working with Bassberry Sims on legal/regulatory guidance
- Long-term vision: full-stack neurology
	- Longitudinal data collection via lightweight clinical agents
	- Digital twins/synthetic patient representations for three use cases:

### Development Progress & Team Scaling

- Significant velocity improvement with 8 contractors (4 full-time equivalent)
- Three core product components launching end of January:
- Customer savings demonstration:
	- Texas Neurology: $500k → $180k annual auth staff costs
	- Mind (Michigan): $450k → $240k annual auth staff costs
	- 8-25% overall savings while maintaining quality

### Customer Validation & Pipeline

- Texas Neurology leadership requesting dashboard presentation at Neurona conference
- Invited to Texas Neurology board meeting Friday (unprecedented for vendor)
- AAN CEO interested in dashboards after hearing from Texas Neurology
- Asheville practice MSO contract at final stages
	- $66k Veridgm exit fee acceptable
	- Leadership requesting Autonomy presence at 2026 planning summit
- Replacing Somicare across multiple practices (“30x better” feedback)
- 15-practice consortium providing regular updates, waiting for Texas proof points

### Hiring & Operations Focus

- Four final-round engineering candidates this week (competitive with Translucent, others)
- Single Sprout producing strongest candidates
- Three critical hires planned:
- Strategic throttling of growth to ensure successful implementation
	- Can only handle 3 new customers in next 6 weeks
	- Focus on execution over vanity metrics

Chat with meeting transcript: https://notes.granola.ai/t/8c337844-3cfc-4a36-82bc-dcf56d327860
